Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day
March 14 2019 - 8:00AM
Business Wire
Ophthotech Corporation (Nasdaq: OPHT) announced today that
Kourous A. Rezaei, M.D., Chief Medical Officer, will present an
overview of the Company at the Alliance for Regenerative Medicine’s
(ARM) 7th Annual Cell and Gene Therapy Investor Day in New York,
NY, on Thursday, March 21, 2019 at 2:15 p.m. Eastern Time.
A live video webcast of Dr. Rezaei’s presentation will be
available at: http://www.arminvestorday.com/webcast. An archived
replay of the webcast will be available on the Company’s website at
www.ophthotech.com for 14 days after the conference.
About Ophthotech Corporation
Ophthotech is a biopharmaceutical company specializing in the
development of transformative gene therapies and novel therapeutics
to treat retinal diseases, with a focus on orphan and age related
indications. For more information, please visit www.ophthotech.com.
Forward-looking Statements
Any statements in this press release about Ophthotech's future
expectations, plans and prospects constitute forward-looking
statements for purposes of the safe harbor provisions under the
Private Securities Litigation Reform Act of 1995. Actual results
may differ materially from those indicated by such forward-looking
statements as a result of various important factors. Any
forward-looking statements represent Ophthotech's views only as of
the date of this press release. Ophthotech anticipates that
subsequent events and developments will cause its views to change.
While Ophthotech may elect to update these forward-looking
statements at some point in the future, Ophthotech specifically
disclaims any obligation to do so.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190314005004/en/
Investors:Ophthotech CorporationKathy Galante,
212-845-8231Vice President, Investor Relations and Corporate
Communicationskathy.galante@ophthotech.comorMedia:SmithSolveAlex
Van Rees, 973-442-1555 ext. 111alex.vanrees@smithsolve.com
OPHTHOTECH CORP. (NASDAQ:OPHT)
Historical Stock Chart
From Oct 2024 to Nov 2024
OPHTHOTECH CORP. (NASDAQ:OPHT)
Historical Stock Chart
From Nov 2023 to Nov 2024
